Literature DB >> 19801136

Exercise and end-stage kidney disease: functional exercise capacity and cardiovascular outcomes.

Trisha L Parsons1, Cheryl E King-Vanvlack.   

Abstract

This review examined published reports of the impact of extradialytic and intradialytic exercise programs on physiologic aerobic exercise capacity, functional exercise endurance, and cardiovascular outcomes in individuals with ESKD. Studies spanning 30 years from the first published report of exercise in the ESKD population were reviewed. Studies conducted in the first half of the publication record focused on the efficacy of exercise training programs performed "off"-dialysis with respect to the modification of traditional cardiovascular risk factors, aerobic capacity, and its underlying determinants. In the latter half of the record, there had been a shift to include other client-centered goals such as physical function and quality of life. There is evidence that both intra- and extradialytic programs can significantly enhance aerobic exercise capacity, but moderate-intensity extradialytic programs may result in greater gains in those individuals who initially have extremely poor aerobic capacity. Functionally, substantive improvements in exercise endurance in excess of the minimum clinical significant difference can occur following either low- or moderate-intensity exercise regardless of the initial level of performance. Reductions in blood pressure and enhanced vascular functioning reported after predominantly intradialytic exercise programs suggest that either low- or moderate-intensity exercise programs can confer cardiovascular benefit. Regardless of prescription model, there was an overall lack of evidence regarding the impact of exercise-induced changes in exercise capacity, endurance, and cardiovascular function on a number of relevant health outcomes (survival, morbidity, and cardiovascular risk), and, more importantly, there is no evidence on the long-term impact of exercise and/or physical activity interventions on these health outcomes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19801136     DOI: 10.1053/j.ackd.2009.08.009

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  8 in total

Review 1.  Exosomes as Mediators of the Systemic Adaptations to Endurance Exercise.

Authors:  Adeel Safdar; Mark A Tarnopolsky
Journal:  Cold Spring Harb Perspect Med       Date:  2018-03-01       Impact factor: 6.915

2.  "A Learned Soul to Guide Me": The Voices of Those Living with Kidney Disease Inform Physical Activity Programming.

Authors:  Trisha L Parsons; Clara Bohm; Katherine Poser
Journal:  Physiother Can       Date:  2018       Impact factor: 1.037

Review 3.  Exercise in individuals with CKD.

Authors:  Kirsten L Johansen; Patricia Painter
Journal:  Am J Kidney Dis       Date:  2011-11-23       Impact factor: 8.860

Review 4.  Prehabilitation for the Frail Patient Approaching ESRD.

Authors:  Anoop Sheshadri; Kirsten L Johansen
Journal:  Semin Nephrol       Date:  2017-03       Impact factor: 5.299

5.  The effect of a 9-month hybrid intradialytic exercise training program on nerve conduction velocity parameters in patients receiving hemodialysis therapy.

Authors:  Stefania S Grigoriou; Christina Karatzaferi; Christoforos D Giannaki; Gianna Patramani; Christina Vogiatzi; Georgia I Mitrou; Ioannis Stefanidis; Giorgos K Sakkas
Journal:  Int Urol Nephrol       Date:  2022-07-05       Impact factor: 2.370

Review 6.  Exercise training in chronic kidney disease patients.

Authors:  Erin J Howden; Robert G Fassett; Nicole M Isbel; Jeff S Coombes
Journal:  Sports Med       Date:  2012-06-01       Impact factor: 11.136

7.  Patients' perspectives on the implementation of intra-dialytic cycling--a phenomenographic study.

Authors:  Susanne Heiwe; Helena Tollin
Journal:  Implement Sci       Date:  2012-07-25       Impact factor: 7.327

8.  Effects of 12 months of detraining on health-related quality of life in patients receiving hemodialysis therapy.

Authors:  Clara Suemi Costa Rosa; Christoforos D Giannaki; Argyro Krase; Meropi Mplekou; Stefania S Grigoriou; Ioannis Stefanidis; Eleftherios Lavdas; Aggelos Pappas; Saul Bloxham; Christina Karatzaferi; Giorgos K Sakkas
Journal:  Int Urol Nephrol       Date:  2020-08-14       Impact factor: 2.370

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.